Cargando…

Caution in interpretation of abnormal carbon monoxide diffusion capacity in COVID-19 patients

Reduced K(CO) in discharged patients with COVID-19 suggests persistent abnormalities in gas exchange. Further research is required to understand why. https://bit.ly/2Hb00gq

Detalles Bibliográficos
Autores principales:	Chapman, David G., Badal, Tanya, King, Gregory G., Thamrin, Cindy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Agora
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7651835/ https://www.ncbi.nlm.nih.gov/pubmed/33154026 http://dx.doi.org/10.1183/13993003.03263-2020

Ejemplares similares

Abnormal carbon monoxide diffusion capacity in COVID-19 patients at time of hospital discharge
por: Nusair, Samir
Publicado: (2020)

High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial)
por: Dhooria, Sahajal, et al.
Publicado: (2022)

Abnormal pulmonary function in COVID-19 patients at time of hospital discharge
por: Mo, Xiaoneng, et al.
Publicado: (2020)

Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients
por: Gao, Yi, et al.
Publicado: (2021)

Exercise capacity impairment after COVID-19 pneumonia is mainly caused by deconditioning
por: Jahn, Kathleen, et al.
Publicado: (2022)

The carbon footprint of respiratory treatments in Europe and Canada: an observational study from the CARBON programme
por: Janson, Christer, et al.
Publicado: (2022)

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour
por: Sun, Thomas Yang, et al.
Publicado: (2022)

Face masks, respiratory patients and COVID-19
por: Soriano, Joan B., et al.
Publicado: (2020)

The potential impact of COVID-19-related disruption on tuberculosis burden
por: McQuaid, C. Finn, et al.
Publicado: (2020)

Safety of biweekly α(1)-antitrypsin treatment in the RAPID programme
por: Greulich, Timm, et al.
Publicado: (2018)

Inhaled corticosteroids for outpatients with COVID-19: a meta-analysis
por: Lee, Todd C., et al.
Publicado: (2022)

Vitamin D status and seroconversion for COVID-19 in UK healthcare workers
por: Faniyi, Aduragbemi A., et al.
Publicado: (2021)

Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19
por: Faniyi, Aduragbemi A., et al.
Publicado: (2021)

COVID-19 pneumothorax in the UK: a prospective observational study using the ISARIC WHO clinical characterisation protocol
por: Marciniak, Stefan J., et al.
Publicado: (2021)

Predictors of severe COVID-19 in a registry-based Swedish cohort of patients with COPD
por: Stridsman, Caroline, et al.
Publicado: (2021)

Added value of chest computed tomography in suspected COVID-19: an analysis of 239 patients
por: Korevaar, Daniël A., et al.
Publicado: (2020)

Increased focus on non-animal models for COVID-19 and non-COVID lung research
por: Gribaldo, Laura, et al.
Publicado: (2021)

A cuckoo COVID coincidence?
por: Chalmers, James D., et al.
Publicado: (2020)

Home monitoring reduced short stay admissions in suspected COVID-19 patients: COVID-box project
por: Dirikgil, Ebru, et al.
Publicado: (2021)

COVID-19 phenotypes: leading or misleading?
por: Gattinoni, Luciano, et al.
Publicado: (2020)

Response to COVID-19 phenotyping correspondence
por: Bos, Lieuwe D.J., et al.
Publicado: (2020)

Healthcare workers with COVID-19 in Mexico
por: Ñamendys-Silva, Silvio A.
Publicado: (2020)

On tuberculosis and COVID-19 co-infection
por: Tadolini, Marina, et al.
Publicado: (2020)

Current smoking is not associated with COVID-19
por: Rossato, Marco, et al.
Publicado: (2020)

COVID-19 and the nicotinic cholinergic system
por: Farsalinos, Konstantinos, et al.
Publicado: (2020)

Proteinase release from activated neutrophils in mechanically ventilated patients with non-COVID-19 and COVID-19 pneumonia
por: Seren, Seda, et al.
Publicado: (2021)

The (in)significance of TB and COVID-19 co-infection
por: Khurana, Alkesh Kumar, et al.
Publicado: (2020)

Correlation and causality: a COVID-19 conundrum
por: Morice, Alyn H.
Publicado: (2020)

COVID-19 and smoking: is nicotine the hidden link?
por: Russo, Patrizia, et al.
Publicado: (2020)

Pulmonary embolism in patients with COVID-19 pneumonia
por: Bompard, Florian, et al.
Publicado: (2020)

Reply to: “Current smoking is not associated with COVID-19”
por: Leung, Janice M., et al.
Publicado: (2020)

Is high-dose glucocorticoid beneficial in COVID-19?
por: Muthu, Valliappan, et al.
Publicado: (2021)

The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19
por: Klok, Frederikus A., et al.
Publicado: (2020)

Automated lung sound analysis using the LungPass platform: a sensitive and specific tool for identifying lower respiratory tract involvement in COVID-19
por: Lapteva, Elena A., et al.
Publicado: (2021)

Does bronchoscopy help the diagnosis in COVID-19 infection?
por: Ora, Josuel, et al.
Publicado: (2020)

Smoking, ACE-2 and COVID-19: ongoing controversies
por: Leung, Janice M., et al.
Publicado: (2020)

COVID-19 in Italy: passing through bitter waters
por: Guglielmetti, Lorenzo, et al.
Publicado: (2020)

COVID-19 and nicotine as a mediator of ACE-2
por: Leung, Janice M., et al.
Publicado: (2020)

Arterial hypertension and the risk of severity and mortality of COVID-19
por: Leiva Sisnieguez, Carlos Enrique, et al.
Publicado: (2020)

Cardiovascular comorbidity and its impact on patients with COVID-19
por: Guan, Wei-jie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t7pl8e1b4irt9q0vvvoebskcbr